US institute seeks to bridge bench-to-bedside gap.
McCarthy
Michael
M
D000927:Anticonvulsants / Q000627:therapeutic use; D003142:Communication; D004345:Drug Industry / Q000639:trends; D006801:Humans; D009316:National Institutes of Health (U.S.) / Q000191:economics; D009422:Nervous System Diseases / Q000235:genetics / Q000628:therapy*; D018696:Neuroprotective Agents / Q000627:therapeutic use; D009488:Neurosciences / Q000639:trends*; D035583:Rare Diseases / Q000191:economics / Q000628:therapy; D012109:Research Support as Topic; D020521:Stroke / Q000235:genetics / Q000628:therapy*; D014481:United States
D000927:Anticonvulsants; D018696:Neuroprotective Agents